Merck & Co., Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Merck & Co., Inc. (MRK) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 121.00 thousand shares for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2018-05-08
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-03-31 was 121.00K shares, a 40.70% increase year-over-year.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2017-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2017-06-30 was 4.91M shares, a 0.97% increase year-over-year.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2017-03-31 was 86.00K shares, a 35.34% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month |
|---|---|---|---|---|
| 2018-03-31 | 121.00K shares 10-Q · filed 2018-05-08 | |||
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 4.91M shares derived: sum of 2 quarters · filed 2017-11-07 | 5.00M shares 10-Q · filed 2017-11-07 | |
| 2017-06-30 | 4.91M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 5.00M shares 10-Q · filed 2017-08-08 | ||
| 2017-03-31 | 86.00K shares 10-Q · filed 2018-05-08 | |||
| 2016-09-30 | 1.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 5.87M shares derived: sum of 2 quarters · filed 2017-11-07 | 6.00M shares 10-Q · filed 2017-11-07 | |
| 2016-06-30 | 4.87M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 5.00M shares 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | 133.00K shares 10-Q · filed 2017-05-09 | |||
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | 3.91M shares derived: sum of 2 quarters · filed 2016-11-07 | 4.00M shares 10-Q · filed 2016-11-07 | |
| 2015-06-30 | 3.91M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | 4.00M shares 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | 87.00K shares 10-Q · filed 2016-05-09 | |||
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 4.95M shares derived: sum of 2 quarters · filed 2015-11-05 | 5.00M shares 10-Q · filed 2015-11-05 | |
| 2014-06-30 | 4.95M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 5.00M shares 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | 49.00K shares 10-Q · filed 2015-05-07 | |||
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 5.97M shares derived: sum of 2 quarters · filed 2014-11-10 | 6.00M shares 10-Q · filed 2014-11-10 | |
| 2013-06-30 | 5.97M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 6.00M shares 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | 32.00K shares 10-Q · filed 2014-05-08 | |||
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | 6.97M shares derived: sum of 2 quarters · filed 2013-11-07 | 7.00M shares 10-Q · filed 2013-11-07 | |
| 2012-06-30 | 6.97M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | 7.00M shares 10-Q · filed 2013-08-07 | ||
| 2012-03-31 | 33.00K shares 10-Q · filed 2013-05-09 | |||
| 2011-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | 7.78M shares derived: sum of 2 quarters · filed 2012-11-09 | 8.00M shares 10-Q · filed 2012-11-09 | |
| 2011-06-30 | 7.78M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | 8.00M shares 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | 221.00K shares 10-Q · filed 2012-05-08 | |||
| 2010-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | 9.00M shares derived: sum of 2 quarters · filed 2011-11-08 | 10.00M shares 10-Q · filed 2011-11-08 | |
| 2010-06-30 | 9.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | 10.00M shares 10-Q · filed 2011-08-08 | 9.90M shares 10-Q · filed 2010-08-06 | |
| 2010-03-31 | 1.00M shares 10-Q · filed 2011-05-09 | |||
| 2009-09-30 | 400.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | 2.50M shares 10-Q · filed 2010-11-08 | ||
| 2009-06-30 | 2.10M shares 10-Q · filed 2010-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |